
Single-nucleus RNA sequencing reveals a preclinical model for the most common subtype of glioblastoma
Glioblastoma (GBM) is one of the most aggressive and difficult-to-treat brain cancers. Scientists have learned…
Glioblastoma (GBM) is one of the most aggressive and difficult-to-treat brain cancers. Scientists have learned…
Company to present four abstracts at the American Association for Cancer Research 2025 annual meeting…
Cancer is a complex disease, and even within a single tumor, not all cells are…
Understanding cancer at the cellular level is crucial for developing better treatments and therapies. One…
Recent advancements in single-cell sequencing have allowed scientists to explore the complexity of tissues by…
RNA is more than just a messenger carrying genetic instructions—it undergoes complex modifications that can…
A new paper from Elham Azizi’s lab at Columbia University in the City of New York…
From Parse Biosciences Cells profiled in each publication double every year. Experimental size is growing…
Remix Therapeutics (Remix), a clinical-stage biotechnology company developing small molecule therapies to modulate RNA processing…
PacBio, a leading developer of high-quality, highly accurate sequencing solutions, today announced the signing of…